POINT BIOPHARMA GLOBAL INC - COM (PNT) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q1 2024

Type / Class
Equity / COM
Symbol
PNT
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of POINT BIOPHARMA GLOBAL INC - COM (PNT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$1,000 0
2023 Q4 127 $1,000 -$410,970,425 $12.50 1
2023 Q3 61,615,065 $410,971,425 -$15,499,355 $6.67 125
2023 Q2 62,985,351 $570,600,331 +$5,179,651 $9.06 129
2023 Q1 62,587,229 $455,008,320 +$10,612,601 $7.27 113
2022 Q4 61,148,715 $445,772,118 -$528,079 $7.29 108
2022 Q3 60,879,303 $470,579,856 +$104,042,379 $7.73 102
2022 Q2 48,513,613 $330,390,209 +$56,257,719 $6.81 80
2022 Q1 39,878,866 $317,779,054 +$44,804,928 $7.97 65
2021 Q4 34,712,625 $194,388,920 +$13,130,935 $5.60 54
2021 Q3 32,212,806 $247,729,000 +$240,039,000 $7.69 34